4//SEC Filing
Caissa Capital Management ltd. 4
Accession 0001929354-23-000015
CIK 0001534120other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 4:04 PM ET
Size
9.8 KB
Accession
0001929354-23-000015
Insider Transaction Report
Form 4
Caissa Capital Management ltd.
10% Owner
Transactions
- Purchase
Common Stock
2023-06-15$3.68/sh+3,160$11,640→ 1,420,700 total(indirect: See Footnote (1)) - Purchase
Common Stock
2023-06-16$3.90/sh+3,000$11,714→ 1,423,700 total(indirect: See Footnote (1)) - Purchase
Common Stock
2023-06-20$4.14/sh+2,000$8,289→ 1,425,700 total(indirect: See Footnote (1))
Holdings
- 182,300
Common Stock
Footnotes (5)
- [F1]Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.19 to $3.99, inclusive.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.745 to $3.98, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.07 to $4.17, inclusive.
- [F5]These shares are directly owned by Mr. Golestaneh in his personal capacity.
Documents
Issuer
Avalo Therapeutics, Inc.
CIK 0001534120
Entity typeother
IncorporatedVirgin Islands, British
Related Parties
1- filerCIK 0001929354
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 4:04 PM ET
- Size
- 9.8 KB